The Asia-Pacific hospital-acquired infection diagnostics market accounted for $418.937 million in 2019, and is expected to reach $780.882 million by 2027, registering a CAGR of 7.5% from 2020 to 2027.
The rationale for adding more respiratory viruses like flu and RSV is that, last winter, we actually had more of those cases. Those are picking back up again. And our last winter was basically split ...
The new hand gel, produced by Primel, being tested in Royal Preston Hospital Pic: Primel/Lancashire Teaching Hospitals A world-first in health-protecting ha ...